First Time Loading...

Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 177.8 SEK -0.73% Market Closed
Updated: May 21, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Biotage AB

Revenue
2B SEK
Cost of Revenue
-749m SEK
Gross Profit
1.2B SEK
Operating Expenses
-905m SEK
Operating Income
327m SEK
Other Expenses
-91m SEK
Net Income
236m SEK

Margins Comparison
Biotage AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
Biotage AB
STO:BIOT
14.2B SEK
62%
17%
12%
US
Thermo Fisher Scientific Inc
NYSE:TMO
226.7B USD
40%
17%
14%
US
Danaher Corp
NYSE:DHR
197.8B USD
58%
22%
18%
US
Agilent Technologies Inc
NYSE:A
45.3B USD
51%
19%
18%
CH
Lonza Group AG
SIX:LONN
38.2B CHF
36%
20%
10%
US
IQVIA Holdings Inc
NYSE:IQV
41.8B USD
35%
14%
9%
KR
Samsung Biologics Co Ltd
KRX:207940
55.5T KRW
49%
30%
23%
US
Mettler-Toledo International Inc
NYSE:MTD
32.4B USD
59%
29%
21%
IE
ICON PLC
NASDAQ:ICLR
26.4B USD
30%
13%
8%
US
West Pharmaceutical Services Inc
NYSE:WST
25B USD
37%
23%
19%
US
Waters Corp
NYSE:WAT
21B USD
60%
27%
21%
Country SE
Market Cap 14.2B SEK
Gross Margin
62%
Operating Margin
17%
Net Margin
12%
Country US
Market Cap 226.7B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 197.8B USD
Gross Margin
58%
Operating Margin
22%
Net Margin
18%
Country US
Market Cap 45.3B USD
Gross Margin
51%
Operating Margin
19%
Net Margin
18%
Country CH
Market Cap 38.2B CHF
Gross Margin
36%
Operating Margin
20%
Net Margin
10%
Country US
Market Cap 41.8B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country KR
Market Cap 55.5T KRW
Gross Margin
49%
Operating Margin
30%
Net Margin
23%
Country US
Market Cap 32.4B USD
Gross Margin
59%
Operating Margin
29%
Net Margin
21%
Country IE
Market Cap 26.4B USD
Gross Margin
30%
Operating Margin
13%
Net Margin
8%
Country US
Market Cap 25B USD
Gross Margin
37%
Operating Margin
23%
Net Margin
19%
Country US
Market Cap 21B USD
Gross Margin
60%
Operating Margin
27%
Net Margin
21%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Biotage AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Biotage AB
STO:BIOT
14.2B SEK
8%
6%
10%
9%
US
Thermo Fisher Scientific Inc
NYSE:TMO
226.7B USD
13%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
197.8B USD
16%
10%
12%
10%
US
Agilent Technologies Inc
NYSE:A
45.3B USD
21%
11%
14%
14%
CH
Lonza Group AG
SIX:LONN
38.2B CHF
7%
4%
9%
8%
US
IQVIA Holdings Inc
NYSE:IQV
41.8B USD
23%
5%
10%
9%
KR
Samsung Biologics Co Ltd
KRX:207940
55.5T KRW
9%
5%
9%
6%
US
Mettler-Toledo International Inc
NYSE:MTD
32.4B USD
-849%
23%
48%
28%
IE
ICON PLC
NASDAQ:ICLR
26.4B USD
8%
4%
8%
6%
US
West Pharmaceutical Services Inc
NYSE:WST
25B USD
21%
16%
22%
20%
US
Waters Corp
NYSE:WAT
21B USD
69%
15%
26%
20%
Country SE
Market Cap 14.2B SEK
ROE
8%
ROA
6%
ROCE
10%
ROIC
9%
Country US
Market Cap 226.7B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 197.8B USD
ROE
16%
ROA
10%
ROCE
12%
ROIC
10%
Country US
Market Cap 45.3B USD
ROE
21%
ROA
11%
ROCE
14%
ROIC
14%
Country CH
Market Cap 38.2B CHF
ROE
7%
ROA
4%
ROCE
9%
ROIC
8%
Country US
Market Cap 41.8B USD
ROE
23%
ROA
5%
ROCE
10%
ROIC
9%
Country KR
Market Cap 55.5T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
6%
Country US
Market Cap 32.4B USD
ROE
-849%
ROA
23%
ROCE
48%
ROIC
28%
Country IE
Market Cap 26.4B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 25B USD
ROE
21%
ROA
16%
ROCE
22%
ROIC
20%
Country US
Market Cap 21B USD
ROE
69%
ROA
15%
ROCE
26%
ROIC
20%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More